Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...
AstraZeneca still has a phase 1-stage GLP-1 agonist being assessed for metabolic dysfunction-associated steatohepatitis as well as a FAP inhibitor that’s due to read out later this year. (James ...
IN A COUNTRY struggling to find reasons for cheer, British life sciences offer a ray of hope. The £108bn ($145bn) industry employs more than 300,000 people, many in high-value jobs, and Britain is a ...
(Reuters) -AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump ...
The European Union is calling out vaccine makers AstraZeneca and Pfizer over delivery delays that could slow its recovery from the pandemic. Officials are even threatening to restrict exports and take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results